natgillin/translations-raw huggingface dataset:
The Equity facility, which will be primarily demand-driven, shall use a portfolio approach, where venture capital funds and other comparable intermediaries select the firms to be invested in.
Kapitalski instrument, ki bo predvsem usmerjen v povpraševanje, uporablja portfeljski pristop, pri katerem skladi tveganega kapitala in drugi primerljivi posredniki izberejo podjetja, v katera se bo vlagalo.
Earmarking may be applied to help achieve particular policy goals, building on the positive experience in the Competitiveness and Innovation Framework Programme (2007 to 2013) with earmarking for eco-innovation, for example for achieving goals related to the identified societal challenges.
Da bi pripomogli k doseganju določenih ciljev politike, na primer ciljev, povezanih z opredeljenimi družbenimi izzivi, bi lahko uporabili sistem dodeljevanja sredstev, temelječ na pozitivnih izkušnjah, pridobljenih pri Okvirnem programu za konkurenčnost in inovativnost (2007 do2013) v zvezi z dodeljevanjem sredstev za ekološke inovacije.
The start-up window, supporting the seed and early stages, shall enable equity investments in, amongst others, knowledge-transfer organisations and similar bodies through support to technology transfer (including the transfer of research results and inventions stemming from the sphere of public research to the productive sector, for example through proof-of-concept), seed capital funds, cross-border seed and early-stage funds, business angel co-investment vehicles, intellectual property assets, platforms for the exchange and trading of intellectual property rights, and early-stage venture capital funds and funds-of-funds operating across borders and investing in venture capital funds.
Del za zagon podjetij, ki podpira zagon in zgodnje faze dejavnosti, omogoča naložbe kapitala med drugim v organizacije za prenos znanja in podobne organe, in sicer prek podpor za prenos tehnologije (tudi prenos rezultatov raziskav in izumov, ki izhajajo iz javnih raziskav, v proizvodni sektor, na primer na podlagi potrditve koncepta), sklade začetnega kapitala, čezmejne sklade zagonskega kapitala in kapitala za zgodnjo fazo, instrumente sofinanciranja poslovnih angelov, sredstva za intelektualno lastnino, platforme za izmenjavo pravic intelektualne lastnine in trgovanje z njimi ter sklade tveganega kapitala za zgodnjo fazo in čezmejne sklade skladov, ki investirajo v sklade tveganega kapitala.
The growth window shall make expansion and growth-stage investments in conjunction with the Equity Facility for Growth under COSME, including investments in private and public sector funds-of-funds operating across borders and investing in venture capital funds, most of which will have a thematic focus that supports the goals of the Europe 2020 strategy.
Del za rast omogoča naložbe v fazi razširjanja in rasti, skupaj s kapitalskim instrumentom za rast v okviru COSME, vključno z naložbami v čezmejne sklade skladov v zasebnem in javnem sektorju, ki vlagajo v sklade tveganega kapitala in bodo večinoma osredotočeni na temo, ki bo podprla cilje strategije Evropa 2020.
Innovation In SMEs
Inovacije v MSP
The specific objective is to stimulate sustainable economic growth by means of increasing the levels of innovation in SMEs, covering their different innovation needs over the whole innovation cycle for all types of innovation, thereby creating more fast-growing, internationally active SMEs.
Posebni cilj je pospešiti trajnostno gospodarsko rast na podlagi povečanja stopnje inovacij v MSP, z vključitvijo njihovih različnih inovacijskih potreb v celotnem inovacijskem ciklu za vse vrste inovacij, s tem pa ustvariti več hitro rastočih, mednarodno dejavnih MSP.
Considering the central role of SMEs in Europe's economy, research and innovation in SMEs will play a crucial role in increasing competitiveness, boosting economic growth and job creation and thus in achieving the objectives of the Europe 2020 strategy and notably its flagship initiative 'Innovation Union'.
Glede na osrednjo vlogo MSP v gospodarstvu Evrope bodo imele raziskave in inovacije v MSP ključno vlogo pri večanju konkurenčnosti, spodbujanju gospodarske rasti in ustvarjanju delovnih mest in s tem doseganju ciljev iz strategije Evropa 2020, zlasti pa iz njene vodilne pobude "Unija inovacij".
However, SMEs have – despite their important economic and employment share and significant innovation potential – several types of problems to become more innovative and more competitive, including shortage of financial resources and access to finance, shortage in skills in innovation management, weaknesses in networking and cooperation with external parties, and insufficient use of public procurement to foster innovation in SMEs.
Vendar se MSP kljub svojemu pomembnemu deležu v gospodarstvu in zaposlovanju ter precejšnjemu inovacijskemu potencialu srečujejo z vrsto različnih problemov, ki jim otežujejo doseganje večje inovativnosti in konkurenčnosti, med drugim s pomanjkanjem finančnih sredstev in dostopa do financiranja, pomanjkljivimi spretnostmi na področju upravljanja inovacij, slabostmi na področju mreženja in sodelovanja z zunanjimi partnerji ter nezadostno uporabo javnih naročil za spodbujanje inovacij v MSP.
Although Europe produces a similar number of start-up companies to the United States, European SMEs are finding it much harder to grow into large companies than their US counterparts.
Čeprav je v Evropi podobno število zagonskih podjetij kot v Združenih državah, se evropska MSP precej težje razvijejo v velika podjetja, če primerjamo z ZDA.
The internationalised business environment with increasingly interlinked value chains puts further pressure on them.
Mednarodno poslovno okolje z vedno bolj medsebojno povezanimi vrednostnimi verigami nanje izvaja dodaten pritisk.
SMEs need to enhance their research and innovation capacity.
MSP morajo okrepiti svojo raziskovalno in inovacijsko zmogljivost.
They need to generate, take up and commercialise new knowledge and business ideas faster and to a greater extent to compete successfully on fast evolving global markets.
Da bi uspešno konkurirala na hitro rastočih svetovnih trgih, morajo hitreje in v večjem obsegu ustvarjati, uporabljati in komercializirati novo znanje in poslovne zamisli.
The challenge is to stimulate more innovation in SMEs, thereby enhancing their competitiveness, sustainability and growth.
Izziv je v tem, da se v MSP dodatno spodbujajo inovacije, s tem pa povečajo njihova konkurenčnost, vzdržnost in rast.
The proposed actions aim to complement national and regional business innovation policies and programmes, to foster cooperation between SMEs, including transnational cooperation, clusters and other innovation-relevant actors in Europe, to bridge the gap between R&D and successful market uptake, to provide a more business innovation friendly environment, including demand-side measures and measures geared to boosting the transfer of knowledge, and to support taking into account the changing nature of innovation processes, new technologies, markets and business models.
Cilj predlaganih ukrepov je dopolniti nacionalne in regionalne politike in programe poslovnih inovacij, pospeševati sodelovanje med MSP, tudi nadnacionalno sodelovanje, grozdi in drugimi akterji v Evropi, pomembnimi na področju inovacij, premostiti vrzel med raziskavami in razvojem ter uspešno uveljavitvijo na trgu, zagotavljati okolje, prijaznejše do poslovnih inovacij, vključno z ukrepi na strani povpraševanja in ukrepi, usmerjenimi v spodbujanje prenosa znanja, in podpirati upoštevanje spremenljive narave inovacijskih procesov, novih tehnologij, trgov in poslovnih modelov.
Strong links with industry-specific Union policies, notably COSME and the Cohesion Policy Funds, will be established to ensure synergies and a coherent approach.
Vzpostavljene bodo močne povezave s sektorskimi politikami Unije, zlasti s COSME ter skladi kohezijske politike, da bi zagotovili sinergije in skladen pristop.
SMEs are key drivers of innovation due to their ability to quickly and efficiently transform new ideas in successful businesses.
MSP so ključna gonilna sila inovacij zaradi zmožnosti, da nove zamisli hitro in učinkovito preoblikujejo v uspešne posle.
They serve as important conduits of knowledge spill-over bringing research results to the market.
So pomembni kanali za prelivanje znanja, ki rezultate raziskav prinesejo na trg.
SMEs have a key role to play in technology and knowledge transfer processes, contributing to the market transfer of innovations stemming from the research carried out in universities, research bodies and research performing companies.
MSP imajo ključno vlogo pri procesih prenosa tehnologije in znanja ter prispevajo k prenosu inovacij, izhajajočih iz raziskav univerz, raziskovalnih ustanov ter podjetij, ki opravljajo raziskave, na trg.
The last twenty years have shown that entire sectors have been renewed and new industries created driven by innovative SMEs.
Zadnji dve desetletji sta pokazali, da so inovativna MSP pripomogla k prenovi celotnih sektorjev in ustvarjanju novih industrijskih panog.
Fast growing enterprises are crucial for the development of emerging industries and for the acceleration of the structural changes that Europe needs to become a knowledge-based and sustainable economy with sustained growth and high quality jobs.
Hitro rastoča podjetja so ključna za razvoj nastajajočih industrijskih panog in pospeševanje strukturnih sprememb, ki jih Evropa potrebuje, da bi postala na znanju temelječe in trajnostno gospodarstvo s trajnostno rastjo in visokokakovostnimi delovnimi mesti.
SMEs can be found in all sectors of the economy.
MSP so prisotna v vseh sektorjih gospodarstva.
They form a more important part of the European economy than of other regions such as the United States.
So bolj pomemben del evropskega gospodarstva kot pa v drugih območjih, npr. Združenih državah.
All types of SMEs can innovate.
Vse vrste MSP so lahko inovativne.
They need to be encouraged and supported to invest in research and innovation and to enhance their capacity to manage innovation processes.
Treba jih je spodbujati in podpirati, da bi vlagale v raziskave in inovacije, ter krepiti njihovo zmožnost za upravljanje inovacijskih procesov.
In doing so they should be able to draw on the full innovative potential of the internal market and the ERA so as to create new business opportunities in Europe and beyond and to contribute to find solutions to key societal challenges.
Na ta način bodo lahko izkoristila celoten inovacijski potencial notranjega trga in evropskega raziskovalnega prostora, s tem pa ustvarila nove poslovne priložnosti v Evropi in zunaj nje ter prispevala k iskanju rešitev za ključne družbene izzive.
Participation in Union research and innovation strengthens the R&D and technology capability of SMEs, increases their capacity to generate, absorb and use new knowledge, enhances the economic exploitation of new solutions, boosts innovation in products, services and business models, promotes business activities in larger markets and internationalises the knowledge networks of SMEs.
Udeležba pri raziskavah in inovacijah Unije krepi zmogljivost MSP na področju raziskav, razvoja in tehnologije, veča njihovo sposobnost za ustvarjanje, črpanje in uporabo novega znanja, pospešuje gospodarsko izkoriščanje novih rešitev, pospešuje inovacije proizvodov, storitev in poslovnih modelov, spodbuja poslovne dejavnosti na večjih trgih in internacionalizira mreže znanj MSP.
SMEs that have a good innovation management in place, thereby often relying on external expertise and skills, outperform others.
MSP, ki imajo vzpostavljeno dobro upravljanje inovacij, pri čemer se pogosto zanašajo na zunanje strokovno znanje in spretnosti, so uspešnejša od drugih.
Cross-border collaborations are an important element in the innovation strategy of SMEs to overcome some of their size-related problems, such as access to technological and scientific competences and new markets.
Čezmejna sodelovanja so pomemben dejavnik v inovacijski strategiji MSP za premagovanje nekaterih težav, povezanih z njihovo velikostjo, kot je dostop do tehnoloških in znanstvenih sposobnosti in novih trgov.
They contribute to turn ideas into profit and company growth and in return to increase private investment in research and innovation.
Pomagajo, da se zamisli pretvorijo v dobiček in rast podjetja, v zameno pa prispevajo k povečanju zasebnih naložb v raziskave in inovacije.
Regional and national programmes for research and innovation, often backed by European cohesion policy, play an essential role in promoting SMEs.
Regionalni in nacionalni programi za raziskave in inovacije, ki jih pogosto podpre evropska kohezijska politika, imajo ključno vlogo pri spodbujanju MSP.
In particular, Cohesion Policy Funds have a key role to play through building capacity and providing a stairway to excellence for SMEs in order to develop excellent projects that may compete for funding under Horizon 2020.
S krepitvijo zmogljivosti in zagotavljanjem priložnosti za odličnost za MSP imajo zlasti skladi kohezijske politike ključno vlogo pri razvoju odličnih projektov, ki se lahko potegujejo za sredstva v okviru Obzorja 2020.
Nevertheless, only a few national and regional programmes provide funding for transnational research and innovation activities carried out by SMEs, the Union-wide diffusion and uptake of innovative solutions or cross-border innovation support services.
Kljub temu lahko le redki nacionalni in regionalni programi zagotovijo financiranje za nadnacionalne dejavnosti na področju raziskav in inovacij, ki jih izvajajo MSP, za širjenje in uporabo inovativnih rešitev po vsej Uniji ali čezmejne podporne storitve za inovacije.
The challenge is to provide SMEs with thematically open support to realise international projects in line with companies' innovation strategies.
Izziv je v tem, da se MSP zagotovi tematsko odprta podpora za uresničitev mednarodnih projektov v skladu z inovacijskimi strategijami podjetij.
Actions at Union level are therefore necessary to complement activities undertaken at national and regional level, to enhance their impact and to open up the research and innovation support systems.
Ukrepi na ravni Unije so zato potrebni za dopolnjevanje dejavnosti, ki se izvajajo na nacionalni in regionalni ravni, za povečanje njihovega učinka in za odprtje podpornih sistemov na področju raziskav in inovacij.
Mainstreaming SME support especially through a dedicated instrument
Splošna uporaba podpore MSP, zlasti s posebnim namenskim instrumentom
SMEs shall be supported across Horizon 2020.
MSP so podprta na vseh ravneh Obzorja 2020.
For this purpose, to participate in Horizon 2020, better conditions for SMEs shall be established.
V ta namen se vzpostavijo boljši pogoji za sodelovanje MSP v Obzorju 2020.
In addition, a dedicated SME instrument shall provide staged and seamless support covering the whole innovation cycle.
Poleg tega zagotavlja namenski instrument MSP postopno in celovito podporo, v katero je zajet celoten inovacijski cikel.
The SME instrument shall be targeted at all types of innovative SMEs showing a strong ambition to develop, grow and internationalise.
Instrument MSP je namenjen vsem vrstam inovativnih MSP, ki kažejo velike ambicije za razvoj, rast in internacionalizacijo.
It shall be provided for all types of innovation, including service, non-technological and social innovations, given each activity has a clear European added value.
Zagotavlja se za vse vrste inovacij, tudi storitvene, netehnološke in družbene inovacije, pod pogojem, da ima vsaka dejavnost jasno evropsko dodano vrednost.
The aim is to develop and capitalise on the innovation potential of SMEs by filling the gap in funding for early stage high-risk research and innovation, stimulating innovations and increasing private-sector commercialisation of research results.
Cilj je razvoj in izkoriščanje inovacijskega potenciala MSP z zapolnjevanjem vrzeli v financiranju za raziskave in inovacije z visokim tveganjem v začetni fazi, s spodbujanjem inovacij in povečanjem komercializacije rezultatov raziskav v zasebnem sektorju.
The instrument will operate under a single centralised management system, light administrative regime and a single entry point.
Instrument bo deloval na podlagi enotnega centraliziranega sistema upravljanja, z lahko upravno ureditvijo in enotno vstopno točko.
It shall be implemented primarily in a bottom-up manner through a continuously open call.
Izvajal se bo predvsem "od spodaj navzgor" prek stalno odprtih razpisov.
All of the specific objectives of the priority 'Societal challenges', and the specific objective 'Leadership in enabling and industrial technologies' will apply the dedicated SME instrument and allocate an amount for this.
Vsi posebni cilji prednostne naloge „Družbeni izzivi: in posebnega cilja "Vodilni položaj na področju omogočitvenih in industrijskih tehnologij" bodo uporabljali namenski instrument MSP in temu namenili znesek.
Support for research-intensive SMEs
Podpora raziskovalno intenzivnih MSP
The goal is to promote transnational market-oriented innovation of R&D performing SMEs.
Cilj je spodbujati nadnacionalne tržno usmerjene inovacije MSP, ki delujejo na področju raziskav in razvoja.
A specific action shall target research-intensive SMEs in any sectors that show the capability to commercially exploit the project results.
Poseben ukrep je namenjen raziskovalno intenzivnim MSP v vseh sektorjih, ki kažejo zmožnost tržnega izkoriščanja projektnih rezultatov.
This action will be built on the Eurostars Programme.
Ta ukrep bo temeljil na programu Eurostars.
Enhancing the innovation capacity of SMEs
Povečanje inovacijske zmogljivosti MSP
Transnational activities assisting the implementation of and complementing the SME specific measures across Horizon 2020 shall be supported, notably to enhance the innovation capacity of SMEs.
Podprejo se nadnacionalne dejavnosti, ki pomagajo pri izvajanju in dopolnjevanju posebnih ukrepov za MSP na vseh ravneh Obzorja 2020, in sicer da bi se okrepila inovacijsko zmogljivost MSP.
Close cooperation with the National Contact Point (NCP) Network and the Enterprise Europe Network (EEN) is envisaged.
Predvideno je tesno sodelovanje z mrežo nacionalnih kontaktnih točk in Evropsko podjetniško mrežo.
Supporting market-driven innovation
Podpiranje tržno usmerjenih inovacij
Transnational market-driven innovation to improve the framework conditions for innovation shall be supported, and the specific barriers preventing, in particular, the growth of innovative SMEs shall be tackled.
Treba je podpirati tržno usmerjene nadnacionalne inovacije, da bi izboljšali okvirne pogoje za inovacije, in odpraviti posebne ovire, ki preprečujejo zlasti rast inovativnih MSP.
The specific objective is to improve the lifelong health and well-being of all.
Posebni cilj je izboljšati vseživljenjsko zdravje in dobro počutje za vse.
The number of Europeans aged over 65 is expected to nearly double from 85 million in 2008 to 151 million by 2060, and the number of those over 80 is expected to rise from 22 to 61 million in the same period.
Število Evropejcev, starejših od 65 let, naj bi se s 85 milijonov v letu 2008 skoraj podvojilo na 151 milijonov v letu 2060, v istem obdobju pa naj bi se število oseb, starejših od 80 let, z 22 milijonov predvidoma povečalo na 61 milijonov.
Reducing or containing these costs so that they do not become unsustainable depends partly on improving the lifelong health and well-being of all and therefore on the effective prevention, treatment and management of disease and disability.
Zmanjšanje ali ohranjanje teh stroškov na takšni ravni, da ne postanejo nevzdržni, je delno odvisno od izboljšanja vseživljenjskega zdravja in dobrega počutja za vse, torej od učinkovitega preprečevanja, zdravljenja in obvladovanja bolezni in invalidnosti.
Chronic conditions and diseases are major causes of disability, ill-health, health-related retirement and premature death, and present considerable social and economic costs.
Kronične težave in bolezni so pomemben vzrok za invalidnost, slabo zdravje, upokojevanje zaradi zdravstvenih težav in prezgodnjo smrt ter pomenijo precejšnje stroške za družbo in gospodarstvo.
In the Union, cardiovascular disease annually accounts for more than 2 million deaths and costs the economy more than EUR 192 billion while cancer accounts for a quarter of all deaths and is the number one cause of death for people aged 45-64.
V Uniji zaradi bolezni srca in ožilja letno umre več kot 2 milijona ljudi, gospodarstvo pa te bolezni stanejo več kot 192 milijard EUR, medtem ko je rak vzrok za četrtino vseh smrti in poglavitni vzrok smrti pri osebah, starih med 45 in 64 let.
Over 27 million people in the Union suffer from diabetes and over 120 million from rheumatic and musculoskeletal conditions.
Več kot 27 milijonov ljudi v Uniji trpi zaradi sladkorne bolezni in več kot 120 milijonov zaradi revmatičnih in mišično-skeletnih bolezni.
Rare diseases remain a major challenge, affecting approximately 30 million people across Europe.
Še vedno so velik problem redke bolezni, za katerimi trpi približno 30 milijonov ljudi po celi Evropi.
Infectious diseases (e.g. HIV/AIDS, tuberculosis and malaria), are a global concern, accounting for 41 % of the 1,5 billion disability adjusted life years worldwide, with 8 % of these in Europe.
Nalezljive bolezni (npr. HIV/AIDS, tuberkuloza in malarija) so skrb vsega sveta in pomenijo 41 % od 1,5 milijarde invalidnosti prilagojenih let življenja po vsem svetu, 8 % od tega v Evropi.
Poverty-related and neglected diseases are also a global concern.
Bolezni, povezane z revščino, in zapostavljene bolezni so prav tako vprašanje globalnega pomena.
Emerging epidemics, re-emerging infectious diseases (including water-related diseases) and the threat of increasing anti-microbial resistance must also be prepared for.
Pripraviti se je treba tudi na nove epidemije, pojavljajoče se nalezljive bolezni (tudi z vodo povezane bolezni) in nevarnost vedno večje odpornosti na protimikrobna zdravila.
Increased risks for animal-borne diseases should be considered.
Upoštevati bi bilo treba tudi povečano tveganje za bolezni, ki jih prenašajo živali.
Meanwhile, drug and vaccine development processes are becoming more expensive and less effective.
Medtem pa postajajo postopki razvoja zdravil in cepiv dražji in manj učinkoviti.
Efforts to increase the success of drug and vaccine development include alternative methods to replace classical safety and effectiveness testing.
Med prizadevanja za zagotovitev uspešnega razvoja zdravil in cepiv sodijo tudi alternativne metode, ki naj bi zamenjale klasično testiranje varnosti in učinkovitosti.
Persistent health inequalities and the needs of specific population groups (e.g. those suffering from rare diseases) must be addressed, and access to effective and competent health and care systems must be ensured for all Europeans irrespective of their age or background.
Obravnavati je treba problem nenehnih zdravstvenih neenakosti in potrebe specifičnih skupin prebivalstva (na primer ljudi, ki trpijo zaradi redkih boleznih) ter vsem Evropejcem ne glede na njihovo starost ali socialno ozadje zagotoviti dostop do učinkovitih in primernih zdravstvenih sistemov in sistemov oskrbe.
Other factors, such as nutrition, physical activity, wealth, inclusion, engagement, social capital and work, also affect health and well-being, and a holistic approach must be taken.
Tudi drugi dejavniki, kot so prehrana, fizična aktivnost, premoženjski status, vključenost, udejstvovanje, družbeni kapital in delo, vplivajo na zdravje in dobro počutje, zato je pravzaprav potreben celovit pristop.
Due to higher life expectancy the age and population structure in Europe will change.
Zaradi daljše pričakovane življenjske dobe se bosta spremenili starostna struktura in struktura prebivalstva v Evropi.
Therefore, research furthering lifelong health, active ageing and well-being for all will be a cornerstone of the successful adaptation of societies to demographic change.
Zato bodo raziskave za spodbujanje vseživljenjskega zdravja, aktivnega staranja in dobrega počutja temelj uspešnega prilagajanja družb demografskim spremembam.
Disease and disability are not stopped by national borders.
Bolezni in invalidnosti ne poznajo nacionalnih meja.